Background: Recently, insulin analogs have become widely used for the treatment of diabetes. The aim of this study was to determine differences in the antigenicity of insulin analogs and long-term changes in titers in patients with type 2 diabetes.
Methods: Insulin antibodies were examined using polyethylene glycol and protein G methods in 381 patients with type 2 diabetes.